BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6667675)

  • 1. The glycosidic antigen recognised by a novel monoclonal antibody, 75.12, is developmentally regulated on mouse embryonal carcinoma cells.
    Blaineau C; Le Pendu J; Arnaud D; Connan F; Avner P
    EMBO J; 1983; 2(12):2217-22. PubMed ID: 6667675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells.
    Andrews PW; Banting G; Damjanov I; Arnaud D; Avner P
    Hybridoma; 1984; 3(4):347-61. PubMed ID: 6396197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The surface glycolipid antigen specific for the internal cell mass of the mouse blastocyst and of the stem cells of murine teratocarcinoma F9].
    Anfimova ML; Bannikov GA; Troianovskiĭ SM
    Ontogenez; 1989; 20(2):158-63. PubMed ID: 2472584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmentally regulated surface structures of teratocarcinoma stem cells studied by mutant cell lines.
    Dráber P; Vojtísková M
    Cell Differ; 1984 Dec; 15(2-4):249-53. PubMed ID: 6535647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monoclonal antibody which detects a 125 kd glycoprotein on embryonal carcinoma cells and is mitogenic for murine spleen cells.
    Stern P; Gilbert P; Sternberg S; Thompson S; Chada K
    J Reprod Immunol; 1984 Aug; 6(5):313-28. PubMed ID: 6207296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation antigens of mouse teratocarcinoma stem cells defined by monoclonal antibodies.
    Dráber P; Pokorná Z
    Cell Differ; 1984 Dec; 15(2-4):109-13. PubMed ID: 6535637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definition of three species-specific monoclonal antibodies recognizing antigenic structures present on human embryonal carcinoma cells which undergo modulation during in vitro differentiation.
    Blaineau C; Connan F; Arnaud D; Andrews P; Williams L; McIlhinney J; Avner P
    Int J Cancer; 1984 Oct; 34(4):487-94. PubMed ID: 6208154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variant embryonal carcinoma cells lacking SSEA-1 and Forsmann antigens remain developmentally pluripotent.
    Buckalew JJ; Sterman B; Rosenstraus M
    Dev Biol; 1985 Jan; 107(1):134-41. PubMed ID: 2856907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmentally regulated cell surface structures on mouse and human embryonal carcinoma cell lines.
    Avner P; Arnaud D; Blaineau C; Le Pendu J
    Cell Differ; 1985 Jul; 17(1):13-20. PubMed ID: 4028163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human teratocarcinoma stem cells: glycolipid antigen expression and modulation during differentiation.
    Andrews PW
    J Cell Biochem; 1987 Dec; 35(4):321-32. PubMed ID: 3326883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coordinate expression of X and Y haptens during murine embryogenesis.
    Fenderson BA; Holmes EH; Fukushi Y; Hakomori S
    Dev Biol; 1986 Mar; 114(1):12-21. PubMed ID: 2869992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pluripotent human stem-cell clone isolated from the TERA-2 teratocarcinoma line lacks antigens SSEA-3 and SSEA-4 in vitro, but expresses these antigens when grown as a xenograft tumor.
    Andrews PW; Damjanov I; Simon D; Dignazio M
    Differentiation; 1985; 29(2):127-35. PubMed ID: 2412924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells.
    Kannagi R; Cochran NA; Ishigami F; Hakomori S; Andrews PW; Knowles BB; Solter D
    EMBO J; 1983; 2(12):2355-61. PubMed ID: 6141938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overt expression of H-2 serotypes on EC cells is not necessary for host rejection.
    Maher LJ; Dove WF
    Immunogenetics; 1984; 19(4):343-7. PubMed ID: 6715024
    [No Abstract]   [Full Text] [Related]  

  • 15. Serological analysis of early mouse embryo with rat monoclonal antibodies produced against mouse teratocarcinoma cells.
    Hamasima N; Seto M; Momoi T; Takahashi T
    Differentiation; 1985; 28(3):260-7. PubMed ID: 3838958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD30 and its ligand: possible role in regulation of teratoma stem cells.
    Pera MF; Bennett W; Cerretti DP
    APMIS; 1998 Jan; 106(1):169-72; discussion 173. PubMed ID: 9524575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syngeneic antiserum to Nulli SCC1 embryonal carcinoma cells recognizing surface antigens of embryonic cells.
    Hahnel AC; Eddy EM
    J Reprod Immunol; 1983 Nov; 5(6):371-82. PubMed ID: 6644686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A monoclonal antibody which detects a cell surface antigen on murine embryonal carcinoma and early mouse embryo stages may recognize a carbohydrate determinant involving alpha-linked galactose.
    Stern PL; Gilbert P; Heath JK; Furth M
    J Reprod Immunol; 1983 May; 5(3):145-60. PubMed ID: 6191030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells.
    Shevinsky LH; Knowles BB; Damjanov I; Solter D
    Cell; 1982 Oct; 30(3):697-705. PubMed ID: 6183004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two monoclonal antibodies recognizing determinants on human embryonal carcinoma cells react specifically with the liver isozyme of human alkaline phosphatase.
    Andrews PW; Meyer LJ; Bednarz KL; Harris H
    Hybridoma; 1984; 3(1):33-9. PubMed ID: 6205984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.